Pages that link to "Q88268366"
Jump to navigation
Jump to search
The following pages link to Michael Mannstadt (Q88268366):
Displaying 28 items.
- Autosomal Dominant Hypocalcemia (Hypoparathyroidism) Types 1 and 2 (Q28076495) (← links)
- Management of Hypoparathyroidism: Present and Future (Q33570607) (← links)
- Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis (Q33932297) (← links)
- A Homozygous [Cys25]PTH(1-84) Mutation That Impairs PTH/PTHrP Receptor Activation Defines a Novel Form of Hypoparathyroidism (Q36087092) (← links)
- Effects of phosphate binders in moderate CKD (Q36109201) (← links)
- Fanconi-Bickel syndrome and autosomal recessive proximal tubulopathy with hypercalciuria (ARPTH) are allelic variants caused by GLUT2 mutations. (Q36293480) (← links)
- Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation (Q36329727) (← links)
- Diphtheria Toxin- and GFP-Based Mouse Models of Acquired Hypoparathyroidism and Treatment With a Long-Acting Parathyroid Hormone Analog (Q36889072) (← links)
- Dominant-negative GCMB mutations cause an autosomal dominant form of hypoparathyroidism. (Q36938300) (← links)
- Mutational analysis of GCMB, a parathyroid-specific transcription factor, in parathyroid adenoma of primary hyperparathyroidism (Q36946892) (← links)
- Identification and characterization of C106R, a novel mutation in the DNA‐binding domain of GCMB, in a family with autosomal‐dominant hypoparathyroidism (Q36982359) (← links)
- Germline mutations affecting Gα11 in hypoparathyroidism (Q37113998) (← links)
- Hypoparathyroidism and central diabetes insipidus: in search of the link. (Q37406179) (← links)
- Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study (Q37578427) (← links)
- Knockin mouse with mutant Gα11 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors (Q37624367) (← links)
- Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors (Q41438187) (← links)
- Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study (Q45250281) (← links)
- Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism. (Q46004981) (← links)
- Safety and Efficacy of Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism Randomly Assigned to Receive Fixed 25-μg or 50-μg Daily Doses (Q49888245) (← links)
- Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate (Q51152118) (← links)
- Hypoparathyroidism (Q51799713) (← links)
- Interrelated role of Klotho and calcium-sensing receptor in parathyroid hormone synthesis and parathyroid hyperplasia. (Q52721559) (← links)
- A new multi-system disorder caused by the Gαs mutation p.F376V (Q57476154) (← links)
- OR30-1 Safety and Efficacy of Recombinant Human Parathyroid Hormone 1-84 for the Treatment of Adults with Chronic Hypoparathyroidism: Six-Year Results of the RACE Study. (Q64940563) (← links)
- Rapid detection of intact FGF-23 in tumor tissue from patients with oncogenic osteomalacia (Q81561740) (← links)
- Hypoparathyroidism (Q89146822) (← links)
- Incidence of Hypoparathyroidism After Thyroid Cancer Surgery in South Korea, 2007-2016 (Q92146937) (← links)
- Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism (Q92337205) (← links)